A transversal study was carried out in order to evaluate the prevalence of erectile dysfunction (ED) in adult kidney transplant patients of our region (N ¼ 243), and to investigate the sociodemographic, analytic, and clinical factors associated with it. To evaluate ED, the Spanish five items version of the International Index of Erectile Function (IIEF-5) was employed. Sociodemographic, analytic, and clinical data, including 12 cardiovascular risk factors, were also collected. A total of 199 patients (82%) were included. The median age was 52 y (43-62 y); 106 patients (54.9%) presented with ED. Variables associated with ED were: higher age; longer time on dialysis prior to transplantation; higher comorbidity; presence of diabetes mellitus; had undergone prostatic surgery or peripheric artheriopathy; lower diastolic pressure; and some anti hypertensive drugs. Logistic Regression Model performed step by step showed (R 2 ¼ 0.52) that factors independently associated with ED were: age, time on dialysis previous to transplant, and peripheric artheriopathy.
Introduction
Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient to allow satisfactory sexual intercourse and is part of the general male sexual dysfunction termed impotence that includes libidinal, orgasmic, and ejaculatory dysfunction. 1 The prevalence of ED in the general population is high, ranging from 10 to 52% of men of USA. 2 Recently published data from Spain 3 showed that prevalence in the general population between 25 and 70 y is 18.9% according to the erectile function domain of the International Index of Erectile Function. It is one of the most common chronic medical disorders in men over the age of 40 y. In the Massachusetts Male Aging Study, 4 35% of men aged 40-70 y reported moderate or complete impotence, with 52% of the whole group reporting some degree of ED. The prevalence of ED increases with age as 55% of the men are 75 y old, and 65% of the men 80 y old. This high prevalence makes ED as a relevant health problem.
Several vascular risk factors, as age, diabetes mellitus, smoking, hypertension and dyslipemia, are related to the presence of ED. Although age is associated with increased likelihood of many of the risk factors for ED, the assumption that ED is a natural concomitant of the aging process is not justified. 5 End-stage renal disease is frequently associated with ED. In total, 50% of patients with end-stage renal disease and 75% of patients on chronic dialysis therapy are affected. 6 Causes are primarily organic in nature and are related to uremia as well as the other comorbid conditions that frequently accompany the chronic renal failure patient. Fatigue and psychosocial factors related to the presence of a chronic disease are also contributory factors. 7 In a cross-sectional study in 323 kidney transplant patients, 8 authors found that factors significantly and negatively related to ED were: age, time on dialysis, and iterative transplants. There is not a lot of information about ED of renal transplant bearers, but among the risk factors are underlying vascular factors, hypogonadism associated with immunosuppressive doses of steroids, and neurogenic factors associated with the main diagnosis (eg diabetes). 9 Anxiety, changes in self-image, medication side effects, or interference with penis vascularity and sinusoidal response to neurotransmitters are other factors that have been involved in ED of renal transplant patients. 10 Some authors have reported that after kidney transplantation, sexual function may improve with reference to the previous situation during dialysis treatment.
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Although for some men erectile function may not be the most important measure of sexual satisfaction, for many men, ED creates mental stress that affects their interactions with family and associates. 5 It seems interesting to investigate ED of renal transplant bearers as it is a relatively unknown problem. Actually renal transplant patients are considered as special kind of chronic patients with high survival rates and with a health-related quality of life similar to that of the general population. 12 Knowledge of the factors associated with ED in this group of patients, will allow us to design intervention strategies to solve the problem, and so to improve their health-related quality of life. So, the aims of the present study were to evaluate the prevalence of ED and its degree of severity in kidney transplant patients, and to investigate the sociodemographic and clinical factors that are associated with ED.
Subjects and methods
A descriptive cross-sectional study was carried out on male patients aged over 18 y with end-stage renal disease bearing a functioning kidney transplant in Asturias, a region of Spain, on April 31, 2000. To evaluate the ED, the Spanish version of five items of the International Index of Erectile Function (IIEF-5 items) was employed. A complete data collection record was designed for the study with sociodemographic and clinical data including 12 cardiovascular risk factors.
A letter was sent to each patient (N ¼ 243) inviting them to participate in the study. Patients who did not answer the letter within 3 months were contacted by telephone. Finally, 39 patients refused to participate in the study. Of the remaining 204 patients who answered the letter or the telephone call, five patients were excluded: two patients returned to dialysis treatment during the data collection period; two patients suffered psychiatric disease and so they were unable to answer the questionnaire; and one patient moved out to another region during the data collection period. All included patients were interviewed by the same physician using the IIEF-5 items questionnaire.
(a) The Spanish version of five items of the IIEF-5 was translated from the original version. 13 This is a screening program that evaluates the presence of ED, defining it as the inability to achieve or maintain an erection sufficient to allow satisfactory sexual intercourse. It has five items, scoring from 0 to 5. The total score ranges from 0 to 25 points, and the cutoff points proposed by the authors are: 0-7, severe dysfunction; 8-11, moderate dysfunction; 12-16, mild-to-moderate dysfunction; 17-21, mild dysfunction; and 22-25, no dysfunction. So, a score equal or less than 21 points indicates the presence of ED with a sensitivity of 0.98 and a specificity of 0.88.
(b) Sociodemographic data: age at the moment of the interview; socioeconomic level, deduced from the monthly family income; living conditions (patients living alone); sexual partner and job status.
(c) Clinical data: The main diagnosis of renal disease was classified into six groups; time in each modality of renal replacement therapy and total time in renal replacement therapy in months; number of kidney transplants; body mass index (defined as weight/height 2 ); smoking status; alcoholism; number of acute rejections of the renal allograft; hypertension (defined as arterial tension Z140-90 mmHg); lipemia; isquemic heart disease; peripheric arteriopathy; previous aorto-iliac surgery, and/or prostatic surgery; systolic and diastolic blood pressure and pulse pressure measured in a consulting room; ambulatory blood pressure measure; seric hemoglobin, urea, creatinine at transplant surgery and actual, glucose, total cholesterol, triglyceride, and proteinuria; immunosuppressor treatment and doses (steroids, cyclosporine, azathioprine, mycophenolate mofetil, tacrolimus and Sirolimus); antihypertensive treatment and doses (diuretics, betablockers, alfa-blockers, angiotensin-converting enzyme inhibitorsFACEI, calcium antagonists and angiotensin II receptor antagonistsFARA-II); other treatments and doses. A detailed comorbidity index was also collected. This comorbidity index was employed in other studies 14 and it includes 24 diseases that are defined by specific criteria, each disease having five possible scores (from zero to four), depending on whether the disease is absent, present but not limitating physical activity, or present and producing light, moderate, or severe limitation of physical activity. The addition of each item's score gives a global score that ranges between the theoretical values of 0 and 96.
Statistical procedure
To describe the sample, observed frequencies were used for qualitative variables, and the mean and standard deviation or median and interquartilic range for quantitative variables. Associations between ED (IIEF-5 score equal or less than 21 points) and sociodemographic and clinical variables were studied using w 2 test for qualitative variables, or Student's t-test for continuous quantitative variables. Finally, all variables associated with ED in the bivariate analysis were introduced in a Logistic Regression Model, searching for the variables independently associated with ED.
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Results
Subjects included in the study were 199 male kidney transplanted patients (82% of the male kidney transplanted patients of our region). Patients who refused to participate in the study (N ¼ 39) had a similar median age (49 y) and similar mean time on dialysis previous to kidney transplant (21722.3 months) and mean time with functioning kidney transplant (67.7742.5 months) than that of included patients. We think they were probably patients without ED and so they were not interested in the study. The interviewer in the present study was a clinician, who frequently asked patients about their feelings in relation to their disease, and the patients used to converse with him. Of these 199 interviewed patients, six did not have sexual experience during the last 3 months, so they were considered as nonquantifiable with respect to erectile function. From the remaining 193 interviewed subjects, 106 patients (54.9%) suffered ED. Patients were classified according to the degree of ED as presented in Table 1 .
Sociodemographic and clinical data are presented in Table 2 . As it can be observed, the median age was 52 y, majority of them had a moderate socioeconomic level (between 300 and 1800 h/month), lived with at least one person, had a sexual partner and they were unemployed. The most frequent main diagnosis of renal disease was glomerulonephritis followed by others, which includes unknown etiology. The total mean time on renal replacement therapy was 95.4762.3 months (6-277), 24.8731.2 months (0-217) on dialysis, and 70.5748.6 months (3-207) with a functioning kidney transplant. The majority of patients (81.2%) had received only one Table 3 , patients with ED had higher age, longer time on dialysis prior to transplantation, higher comorbidity, and lower diastolic pressure (measured in office and by ABPM) than patients without ED. Nephrosclerosis diagnosis, prostatic surgery, and peripheric artheriopathy were present more frequently in ED patients. Treatment with alpha-blockers as an antihypertensive was associated with ED, and treatments with beta-blockers as an antihypertensive and Tacrolimus as an immunosuppresor were not associated with not suffering ED.
The Logistic Regression Model (enter method) performed with all the variables associated with ED in the bivariate analysis showed that only the age, the time on dialysis prior to transplantation, and the presence of peripheric arteriopathy were independently associated with ED (Table 4) .
Discussion
ED is a highly sensitive topic touching upon a very private matter, and some patients could answer wrongly. But we think it did not happen or it was not frequent because in the present study the interviewer was a clinician who frequently asked patients about their feelings in relation to their disease and patients used to converse with him.
The prevalence of ED in kidney transplant patients was high and was similar to that described by other authors. In a prospective study, with a small sample size, Burgos et al 15 found that erectile failure decreased after kidney transplantation, with respect to those previously reported in dialysis, from 60 to 45% which is a similar percentage to that shown in the present study for transplant patients. In a small sample of kidney transplant patients, Peskircioglu et al 11 found a prevalence of ED of 32.3%, but this sample had a lower mean age (42.5 vs 52 y in the present study). The prevalence of ED in the present study was also higher than that reported by Rosas et al 16 in all kinds of end-stage renal disease patients (43% of hemodialysis men, 25% of peritoneal dialysis men and 21% of transplant men), but similar to that found in the general population in USA for similar age groups, 4 although higher than that reported in Spain. 3 However, these results were achieved using a different method than that used in the present study. In a recently published study, 3 using the erectile function domain of the IIEF, the overall prevalence in a general population of Spain between 25 and 70 y was 18.9%. So, using the same assessment instrument for ED, the prevalence of ED in kidney transplant patients is clearly higher than that of the general population.
The causes for this high prevalence of ED in kidney transplant patients are probably related with the more frequent presence in patients with endstage renal disease of a variety of associated risk factors such as: increasing age, diabetes mellitus; 16 peripheral neuropathy, autonomic insufficiency, peripheral vascular disease, pharmacologic therapy, psychologic and physical stresses; 7 anxiety, changes in self-image, medication side effects and interference with penis vascularity and sinusoidal response to neurotransmitters; 10 hypothalamic-pituitary-gonadal axis alterations, anemia, secondary hyperparathyroidism, derangements in arterial supply or venous outflow, and the abnormal structure of cavernous body smooth muscle cells. 17 In a study 18 cavernous artery occlusive disease was found in 78% of the studied patients, and all patients who underwent arteriography had diffuse atherosclerotic disease of the distal penile arteries. Patients who received a renal transplant early had vasculogenic impotence only in the case of rejection of the renal transplant, suggesting that early renal transplantation may delay or prevent the development of the penile vasculopathy. This fact could explain our finding of the association between longer time on dialysis and ED as an independent factor. However, in the present study the influence of some of these factors has not been confirmed because they were not studied (peripheral neuropathy, autonomic insufficiency, hypothalamic-pituitary-gonadal axis alterations) or they have not demonstrated association with ED: diabetes, probably because of a small number of patients with this diagnosis; anemia, because patients had an adequate level of hemoglobin; and antihypertensive treatment. So it seems that the influence of antihypertensive treatment on patients suffering ED is less important than that previously described and probably linked to other factors, such as higher age.
As it was shown in the present study, the ED group had a higher mean age, longer time in dialysis prior to transplant, higher comorbidity index, lower diastolic blood pressure measured in office and by ABPM, higher percent of nephrosclerosis as the main diagnosis of renal disease, higher percent of patients suffering from prostatic surgery, higher percent of peripheric arteriopathy higher percent of patients being treated with alpha-blockers and lower percent of patients being treated with betablockers and Tacrolimus than no ED group. With respect to immunosuppressor treatment, we showed that treatment with tacrolimus was associated with no ED, but this is probably because of the lower mean age of the patients with this immunosuppressor treatment. Bellinghieri et al 17 have studied the influence of cyclosporine treatment on sexual hormonal profiles, and they did not find any association of cyclosporine and testicular function in the studied patients.
So our findings confirm the influence of increasing age and peripheral vascular disease on ED. In the present study other new associations with ED were described: higher time in dialysis prior to transplant, higher comorbidity index, lower diastolic blood pressure measured in the office and by ABPM and to have undergone prostatic surgery. The association found for time on dialysis prior to transplant could be due to vascular damage and hormonal changes caused by dialysis treatment. The duration of dialysis is associated with the presence of peripheral vascular disease among patients undergoing hemodialysis. 19 End-stage renal disease causes imbalance in the hypothalamic-pituitarygonadal axis in men. 20 Although renal transplant may effectively reverse many of the hormonal and psychological changes of chronic renal failure, many patients will remain on a transplant waiting list for a considerable length of time, and those patients who develop significant vascular disease may still remain impotent even after successful transplant. 21 The influence of diastolic blood pressure could be due to the more agressive antihypertensive treatment in these patients. The association with prostatic surgery could be due to nervous damage as described.
The factors involved in ED according to the Logistic Regression Model were higher age, the presence of periferic arteriopathy, and longer time on dialysis prior to transplant. The percentage of variance explained for this three factors was 52.1%. So these factors seem to have a lot of significance in the development of ED in kidney transplant patients. Intervention strategies could be designed in order to decrease the consequences of dialysis, and to reduce the time in the waiting list for renal transplantation.
The present study has the limitations of a tranversal study design, but a prospective study could confirm the greater significance of vascular ED in male kidney transplant recepients P Rebollo et al factors over psychological factors described for these patients.
The main conclusions of the present study are: (1) It is necessary to ask patients about erectile function because it is highly prevalent. (2) It is necessary to design intervention strategies in order to decrease the damage caused by dialysis, thus reducing time in the waiting list for renal transplantation.
